About UNC Hospitals, Investigational Drug Service
Clinical Trials at UNC Hospitals, Investigational Drug Service
During the past decade, UNC Hospitals, Investigational Drug Service conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at UNC Hospitals, Investigational Drug Service
According to Clinical.Site data, the most researched conditions in "UNC Hospitals, Investigational Drug Service" are
"Alopecia Areata" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Non-small Cell" (1 trials). Many other conditions were trialed in "UNC Hospitals, Investigational Drug Service" in a lesser frequency.
Clinical Trials Intervention Types at UNC Hospitals, Investigational Drug Service
Most popular intervention types in "UNC Hospitals, Investigational Drug Service" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dacomitinib (PF-00299804)" (1 trials), "Docetaxel" (1 trials), "Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine" (1 trials), "PF-02341066" (1 trials) and "PF-06651600" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UNC Hospitals, Investigational Drug Service
The vast majority of trials in "UNC Hospitals, Investigational Drug Service" are
4 trials for "All" genders.
Clinical Trials Status at UNC Hospitals, Investigational Drug Service
Currently, there are NaN active trials in "UNC Hospitals, Investigational Drug Service".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UNC Hospitals, Investigational Drug Service,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UNC Hospitals, Investigational Drug Service, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".